Journal of Enzyme Inhibition and Medicinal Chemistry,
Journal Year:
2023,
Volume and Issue:
38(1)
Published: April 24, 2023
In
this
article,
emulsomes
(EMLs)
were
fabricated
to
encapsulate
the
N-(5-nitrothiazol-2-yl)-carboxamido
derivatives
(3a-3g)
in
an
attempt
improve
their
biological
availability
and
antiviral
activity.
Next,
both
cytotoxicity
anti-SARS-CoV-2
activities
of
examined
compounds
loaded
EMLs
(F3a-g)
assessed
Vero
E6
cells
via
MTT
assay
calculate
CC50
inhibitory
concentration
50
(IC50)
values.
The
most
potent
3e-loaded
(F3e)
elicited
a
selectivity
index
18
with
IC50
value
0.73
μg/mL.
Moreover,
F3e
was
selected
for
further
elucidation
possible
mode
action
where
results
showed
that
it
exhibited
combination
virucidal
(>90%),
viral
adsorption
(>80%),
replication
(>60%)
inhibition.
Besides,
molecular
docking
MD
simulations
towards
SARS-CoV-2
Mpro
performed.
Finally,
structure-activity
relationship
(SAR)
study
focussed
on
studying
influence
altering
size,
type,
flexibility
α-substituent
carboxamide
addition
compound
contraction
activity.HighlightsEmulsomes
(3a-3g).The
μg/mL
against
SARS-CoV-2.F3e
inhibition.Molecular
docking,
dynamics
(MD)
simulations,
MM-GBSA
calculations
performed.Structure-activity
discussed
Frontiers in Pharmacology,
Journal Year:
2023,
Volume and Issue:
14
Published: May 12, 2023
Taxifolin
is
a
flavonoid
compound,
originally
isolated
from
the
bark
of
Douglas
fir
trees,
which
often
found
in
foods
such
as
onions
and
olive
oil,
also
used
commercial
preparations,
has
attracted
interest
nutritionists
medicinal
chemists
due
to
its
broad
range
health-promoting
effects.
It
powerful
antioxidant
with
excellent
antioxidant,
anti-inflammatory,
anti-microbial
other
pharmacological
activities.
This
review
focuses
on
breakthroughs
taxifolin
for
treatment
diseases
2019
2022
according
various
systems
human
body,
nervous
system,
immune
digestive
basis
this
review,
we
summarize
problems
current
research
try
suggest
solutions
future
directions.
ACS Omega,
Journal Year:
2021,
Volume and Issue:
7(1), P. 875 - 899
Published: Dec. 22, 2021
Cancer
is
a
leading
cause
of
death
worldwide
and
its
incidence
unfortunately
anticipated
to
rise
in
the
next
years.
On
other
hand,
vascular
endothelial
growth
factor
receptor
2
(VEGFR-2)
highly
expressed
tumor-associated
cells,
where
it
affects
tumor-promoting
angiogenesis.
Therefore,
VEGFR-2
considered
one
most
promising
therapeutic
targets
for
cancer
treatment.
Furthermore,
some
FDA-approved
benzimidazole
anthelmintics
have
already
shown
potential
anticancer
activities.
repurposing
them
against
can
provide
rapid
effective
alternative
that
be
implicated
safely
Hence,
13
anthelmintic
drugs
were
subjected
molecular
docking
receptor.
Among
tested
compounds,
fenbendazole
(FBZ,
1),
mebendazole
(MBZ,
2),
albendazole
(ABZ,
3)
proposed
as
antagonists.
dynamics
simulations
carried
out
at
200
ns,
giving
more
information
on
their
thermodynamic
dynamic
properties.
Besides,
activity
aforementioned
was
vitro
three
different
cell
lines,
including
liver
(HUH7),
lung
(A549),
breast
(MCF7)
lines.
The
results
depicted
cytotoxic
especially
both
HUH7
A549
improve
aqueous
solubility
MBZ,
formulated
form
mixed
micelles
(MMs)
which
showed
an
enhanced
drug
release
with
better
cytotoxicity
compared
crude
MBZ.
Finally,
quantification
concentration
treated
cells
has
been
conducted
based
enzyme-linked
immunosorbent
assay.
disclosed
FBZ,
ABZ
significantly
(p
<
0.001)
reduced
VEGFR-2,
while
lowest
inhibition
achieved
MBZ-loaded
MMs,
even
much
than
reference
sorafenib.
Collectively,
investigated
could
encountered
lead
compounds
further
structural
modifications
thus
activity,
accomplished
through
studying
structure–activity
relationships.
New Journal of Chemistry,
Journal Year:
2022,
Volume and Issue:
46(11), P. 5078 - 5090
Published: Jan. 1, 2022
The
pharmacophoric
features
of
the
novel
series
1,3,4-oxadiazole–oxoindole
conjugates
(IVa–g)
as
potential
anti-SARS-CoV-2
agents
based
on
reported
M
pro
inhibitor
(Ia)
are
presented.
Scientific Reports,
Journal Year:
2022,
Volume and Issue:
12(1)
Published: July 28, 2022
Abstract
During
the
current
coronavirus
disease
2019
(COVID-19)
pandemic,
symptoms
of
depression
are
commonly
documented
among
both
symptomatic
and
asymptomatic
quarantined
COVID-19
patients.
Despite
that
many
FDA-approved
drugs
have
been
showed
anti-SARS-CoV-2
activity
in
vitro
remarkable
efficacy
against
clinical
trials,
no
pharmaceutical
products
yet
declared
to
be
fully
effective
for
treating
COVID-19.
Antidepressants
comprise
five
major
drug
classes
treatment
depression,
neuralgia,
migraine
prophylaxis,
eating
disorders
which
frequently
reported
Herein,
eight
prescribed
antidepressants
on
inhibition
SARS-CoV-2
MERS-CoV
was
assessed.
Additionally,
anti-MERS-CoV
activities
were
evaluated.
Furthermore,
molecular
docking
studies
performed
these
spike
(S)
main
protease
(M
pro
)
pockets
MERS-CoV.
Results
Amitriptyline,
Imipramine,
Paroxetine,
Sertraline
had
potential
anti-viral
activities.
Our
findings
suggested
aforementioned
deserve
more
vivo
targeting
especially
those
patients
suffering
from
depression.
Antioxidants,
Journal Year:
2022,
Volume and Issue:
11(3), P. 462 - 462
Published: Feb. 25, 2022
The
immune
system
is
a
potent
army
that
defends
our
body
against
various
infections
and
diseases
through
innate
adaptive
immunity.
Herbal
medicine
one
of
the
essential
sources
for
enhancing
immunity
because
affordability,
availability,
minor
side
effects,
consumers'
preferences.
Hazelnuts,
walnuts,
almonds,
peanuts
are
among
most
widespread
edible
nuts
rich
in
phenolics,
fats,
fibers,
vitamins,
proteins,
minerals.
potential
nut
shells
phytoremediation
has
attracted
increasing
attention
as
sustainable
solution
waste
recycling.
Here,
we
determined
Journal of Medicinal Chemistry,
Journal Year:
2022,
Volume and Issue:
66(1), P. 777 - 792
Published: Dec. 16, 2022
Telomerase
is
an
outstanding
biological
target
for
cancer
treatment.
BIBR1532
a
non-nucleoside
selective
telomerase
inhibitor;
however,
it
experiences
ineligible
pharmacokinetics.
Herein,
we
aimed
to
design
new
BIBR1532-based
analogues
as
promising
inhibitors.
Therefore,
two
novel
series
of
pyridazine-linked
cyclopenta[b]thiophene
(8a-f)
and
tetrahydro-1-benzothiophene
(9a-f)
were
synthesized.
A
quantitative
real-time
polymerase
chain
reaction
was
utilized
investigate
the
inhibitory
activity
candidates.
Notably,
8e
9e
exhibited
best
inhibition
profiles.
Moreover,
showed
strong
antitumor
effects
against
both
MCF-7
A549
cell
lines.
The
on
cycle
apoptosis
measured.
Besides,
evaluated
its
in
vivo
using
solid
Ehrlich
carcinoma.
reduction
tumor
weight
volume
greater
than
doxorubicin.
Also,
molecular
docking
ADME
studies
performed.
Finally,
SAR
study
conducted
gain
further
insights
into
different
potentials
upon
variable
structural
modifications.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(20), P. 12235 - 12235
Published: Oct. 13, 2022
In
this
article,
34
anticoagulant
drugs
were
screened
in
silico
against
the
main
protease
(Mpro)
of
SARS-CoV-2
using
molecular
docking
tools.
Idraparinux,
fondaparinux,
eptifibatide,
heparin,
and
ticagrelor
demonstrated
highest
binding
affinities
towards
Mpro.
A
dynamics
study
at
200
ns
was
also
carried
out
for
most
promising
anticoagulants
to
provide
insights
into
dynamic
thermodynamic
properties
compounds.
Moreover,
a
quantum
mechanical
conducted
which
helped
us
attest
some
findings.
biological
evaluation
(in
vitro)
compounds
performed
by
carrying
MTT
cytotoxicity
assay
crystal
violet
order
assess
inhibitory
concentration
50
(IC50).
It
is
worth
noting
that
displayed
intrinsic
potential
inhibition
with
an
IC50
value
5.60
µM
safety
index
25.33.
addition,
fondaparinux
sodium
dabigatran
showed
activities
values
8.60
9.40
µM,
respectively,
indexes
17.60
15.10,
respectively.
Mpro
enzyme
investigated
utilizing
tipranavir
as
reference
standard.
Interestingly,
attained
2.36
surpassing
(IC50
=
7.38
µM)
more
than
three-fold.
Furthermore,
highly
eligible
10.59
µM.
Finally,
SAR
discussed,
counting
on
findings
both
vitro
approaches.